Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
CompletedOBSERVATIONAL
Enrollment
1,344
Participants
Timeline
Start Date
January 31, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
May 31, 2014
Conditions
Clinically Significant Bacteremia
Trial Locations (1)
41009
Virgen Macarena University Hospital, Seville
All Listed Sponsors
lead
JESUS RODRIGUEZ BAÑO
OTHER
NCT01764490 - Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study | Biotech Hunter | Biotech Hunter